Modulation of the immune response and control of tumour spread by a new synthetic compound
- 1 December 1979
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 66 (12) , 861-863
- https://doi.org/10.1002/bjs.1800661208
Abstract
A small molecular weight biofunctional polymer, NED 137, has been investigated for its anti-neoplastic effect. Through its effect on the immune system, particularly the induction of B cell differentiation to antibody producing cells, this synthetic compound can retard tumour growth and prevent the development of distant metastases. Reactivity to tumour developed following administration of the NED 137. No toxicity has been observed. The polymer NED 137 is now being tested in phase I and phase II clinical trials.Keywords
Funding Information
- Monsanto Co.
- Medical Research Council of Canada
This publication has 5 references indexed in Scilit:
- Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies.Proceedings of the National Academy of Sciences, 1979
- Polyclonal B-cell activators induce immunological response to autologous serum proteinsCellular Immunology, 1977
- Mechanism of B-cell Activation and Self-Non-self DiscriminationPublished by Cold Spring Harbor Laboratory ,1977
- Suggestive Evidence That the “Blocking Antibodies” of Tumor-Bearing Individuals May Be Antigen-Antibody ComplexesProceedings of the National Academy of Sciences, 1971
- DETECTION OF HOMOGRAFT SENSITIVITY IN MICE BY THE ELIMINATION OF CHROMIUM‐51 LABELED LYMPH NODE CELLS*Annals of the New York Academy of Sciences, 1966